Efficacy comparision of bupivacain vs ropivacain in midpoint transverse process to pleura block in modified radical mastectomy surgeries
- Conditions
- Malignant neoplasm of breast, , (2) ICD-10 Condition: O||Medical and Surgical,
- Registration Number
- CTRI/2025/05/087076
- Lead Sponsor
- Pt JNM Medical College Raipur CG
- Brief Summary
This is a randomized Interventional study comparing two drugs I.e. inj. Ropivacaine 0.5% and inj. Bupivacaine 0.25% via midpoint transverse process to pleura block in patients undergoing modified radical mastectomy surgeries in terms of post surgical analgesic efficacy.
Patients will be enrolled with a sample size of 128 ( 64 in each group) , primary outcome will be first rescue analgesia duration using VAS score. Secondary outcome will be patient satisfaction using Likert score .
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Female
- Target Recruitment
- 128
ASA Grade 1 and 2 patients scheduled for elective MRM surgeries.
Patient refusal Patient with COPD and lung disease Patient with severe liver disease Obesity with BMI more than 31 Patient on any analgesics Local site infections Local injury Allergic to study drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post surgical analgesia using VAS score,as first rescue analgesic requirements. Post surgical analgesia using VAS score at 0,2,4,8,10,12,16,20,24 and 48 hours, with Blood pressure, Heart rate, and SpO2 saturation
- Secondary Outcome Measures
Name Time Method Patient satisfaction evaluated using, Likert scale Liberty scale at 0,4,8,12,24 and 48 hours
Trial Locations
- Locations (1)
Dr Bhimrao Ambedakar Memorial Hospital ,Raipur Chhattisgarh
🇮🇳Raipur, CHHATTISGARH, India
Dr Bhimrao Ambedakar Memorial Hospital ,Raipur Chhattisgarh🇮🇳Raipur, CHHATTISGARH, IndiaDr Himanshu DubeyPrincipal investigator9165783431himanshu20192@gmail.com